Fisher & Paykel Healthcare Corporation Share Price and Company Fundamentals
Last traded: Today at 4:59 AM
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Key Metrics
PE ratio
53.42
PB ratio
11.70
Dividend yield
1.14%
Beta
0.93
Market cap
$20.08B
Enterprise value
$19.89B
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Full time employees | 7384 |
| Website | https://www.fphcare.com |
| Mailing address | 15 Maurice Paykel Place East Tamaki Auckland 2013 New Zealand |
| Phone / Fax | 64 9 574 0100 / 64 9 574 0158 |
Dividends
More: Fisher & Paykel Healthcare Corporation Dividend history, yield and payout ratio
Dividend yield
1.14%
Dividend amount
$0.39
Payout ratio
59.47%
5Y Avg. yield
-%
Fisher & Paykel Healthcare Corporation paid $0.39 dividend and the ex-dividend date was 03 Dec 2025.The dividend payout ratio is 59.47%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.FPH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Fisher & Paykel Healthcare Corporation.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Lewis G. Gradon | MD, CEO & Executive Director | 64 | |
| Ms. Lyndal York | Chief Financial Officer | ||
| Mr. Andy Niccol | Chief Operating Officer | ||
| Dr. Andrew Somervell | Vice President of Products & Technology | ||
| Mr. Daniel Adolph | Head of Investor Relations | ||
| Ms. Raelene Leonard | Company Secretary & General Counsel | ||
| Karen Knott | General Manager of Corporate Communications | ||
| Mr. Justin Callahan | VP of Sales & Marketing | ||
| Ms. Nicola Talbot | Vice President of Human Resources | ||
| Mr. Jonathan Rhodes | Vice President Network Design, Facilities, Infrastructure & Sustainability |
Profitability and management effectiveness
Profit margin
20.25%
Operating margin
26.28%
Return on assets
14.25%
Return on equity
22.32%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Fisher & Paykel Healthcare Corporation is 20.08B and its enterprise value is 19.89B. The enterprise value to revenue ratio of FPH is 9.21. The enterprise value to EBITDA ratio of FPH is 28.54.
The FPH's stocks Beta value is 0.93 making it 7% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Fisher & Paykel Healthcare Corporation (FPH)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Fisher & Paykel Healthcare Corporation (ASX:FPH) Frequently Asked Questions
1. What is Fisher & Paykel Healthcare Corporation's Stock Symbol?
Fisher & Paykel Healthcare Corporation trades on ASX under the ticker symbol "FPH".
2. What is Fisher & Paykel Healthcare Corporation's stock price today?
One share of FPH stock can currently be purchased for approximately $34.19.
3. How can I contact Fisher & Paykel Healthcare Corporation?
Fisher & Paykel Healthcare Corporation's mailing address is 15 Maurice Paykel Place East Tamaki Auckland 2013 New Zealand. The company can be reached via phone at 64 9 574 0100.
4. What is Fisher & Paykel Healthcare Corporation's official website?
The official website of Fisher & Paykel Healthcare Corporation is https://www.fphcare.com.